Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kun-Hui Lu

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Immunology and Cell Biology|December 6, 2020
Transforming growth factor β in breast cancer: another new trick for the old dogKun-Hui Lu, Shom Goel
Frontiers in Immunology|January 7, 2016
Dickkopf-3 Contributes to the Regulation of Anti-Tumor Immune Responses by Mesenchymal Stem CellsKun-Hui Lu, Amel Tounsi, Naveen Shridhar, et al.
Nature Immunology|August 6, 2013
Nck-mediated recruitment of BCAP to the BCR regulates the PI(3)K-Akt pathway in B cellsAngelo Castello, Mauro Gaya, Johannes Tucholski, et al.
The Journal of Experimental Medicine|August 12, 2017
PTPN2 regulates T cell lineage commitment and αβ versus γδ specificationFlorian Wiede, Jarrod A Dudakov, Kun-Hui Lu, et al.
Journal of Leukocyte Biology|May 22, 2015
Nck adaptor proteins modulate differentiation and effector function of T cellsKun-Hui Lu, Selina Keppler, Frank Leithäuser, et al.
Cancer Discovery|November 19, 2021
PTP1B Is an Intracellular Checkpoint that Limits T-cell and CAR T-cell Antitumor ImmunityFlorian Wiede, Kun-Hui Lu, Xin Du, et al.
Cancer Discovery|December 4, 2023
INX-315, a Selective CDK2 Inhibitor, Induces Cell Cycle Arrest and Senescence in Solid TumorsCatherine Dietrich, Alec Trub, Antonio Ahn, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 26, 2026
CDK4/6 Inhibition Enhances CAR-T Cell Therapy in Solid TumorsEmily J Lelliott, Jonathan Naddaf, Kun-Hui Lu, et al.
The EMBO Journal|December 6, 2019
PTPN2 phosphatase deletion in T cells promotes anti-tumour immunity and CAR T-cell efficacy in solid tumoursFlorian Wiede, Kun-Hui Lu, Xin Du, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Immunology and Cell Biology|December 6, 2020
Transforming growth factor β in breast cancer: another new trick for the old dogKun-Hui Lu, Shom Goel
Frontiers in Immunology|January 7, 2016
Dickkopf-3 Contributes to the Regulation of Anti-Tumor Immune Responses by Mesenchymal Stem CellsKun-Hui Lu, Amel Tounsi, Naveen Shridhar, et al.
Nature Immunology|August 6, 2013
Nck-mediated recruitment of BCAP to the BCR regulates the PI(3)K-Akt pathway in B cellsAngelo Castello, Mauro Gaya, Johannes Tucholski, et al.
The Journal of Experimental Medicine|August 12, 2017
PTPN2 regulates T cell lineage commitment and αβ versus γδ specificationFlorian Wiede, Jarrod A Dudakov, Kun-Hui Lu, et al.
Journal of Leukocyte Biology|May 22, 2015
Nck adaptor proteins modulate differentiation and effector function of T cellsKun-Hui Lu, Selina Keppler, Frank Leithäuser, et al.
Cancer Discovery|November 19, 2021
PTP1B Is an Intracellular Checkpoint that Limits T-cell and CAR T-cell Antitumor ImmunityFlorian Wiede, Kun-Hui Lu, Xin Du, et al.
Cancer Discovery|December 4, 2023
INX-315, a Selective CDK2 Inhibitor, Induces Cell Cycle Arrest and Senescence in Solid TumorsCatherine Dietrich, Alec Trub, Antonio Ahn, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 26, 2026
CDK4/6 Inhibition Enhances CAR-T Cell Therapy in Solid TumorsEmily J Lelliott, Jonathan Naddaf, Kun-Hui Lu, et al.
The EMBO Journal|December 6, 2019
PTPN2 phosphatase deletion in T cells promotes anti-tumour immunity and CAR T-cell efficacy in solid tumoursFlorian Wiede, Kun-Hui Lu, Xin Du, et al.
Pageof 1